InvestorsHub Logo
Followers 44
Posts 4440
Boards Moderated 0
Alias Born 03/20/2015

Re: beartrap12 post# 690888

Sunday, 05/12/2024 6:52:59 PM

Sunday, May 12, 2024 6:52:59 PM

Post# of 694212
I agree.
If someone needs the money that is one thing but if they are just selling NWBO to put it in a different investment there is no better investment than NWBO.
DCVAX-L for GBM is relatively low risk for approval assuming that the big money rat bastards don't have their hooks into the regulatory agencies.
That will get the stock price back in the range it should and also provide windfall revenue to NWBO to branch out into other areas.
DCVAX-L for other solid tumors
DCVAX-Direct for inoperable solid tumors.
This is an industry disruptive technology that will provide what is effectively a cure for a significant portion of the patients even for cancers that really have not effective treatment today.
If NWBO does not sell they will be the cornerstone for pretty much all future solid tumor cancer treatments which will start with cancer antigen sensitized dendritic cells.
Big pharma will start with that and then add specialized co-treatments like Poly-ICLC or checkpoint inhibitor like Keytruda
Bullish
Bullish

Men who are occupied in the restoration of health to other men, by the joint exertion of skill and humanity, are above all the great of the earth. They even partake of divinity, since to preserve and renew is almost as noble as to create.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News